Skip to main content
. 2015 Aug 4;8:2033–2043. doi: 10.2147/OTT.S88700

Figure 4.

Figure 4

Subgroup analysis of OS comparing chemotherapy and control groups.

Notes: (A) Subgroup analysis of OS in stage I. (C) Subgroup analysis of OS in stage IA. (B) Subgroup analysis of OS in stage IB. (D) Subgroup analysis of OS in cisplatin-based chemotherapy. (E) Subgroup analysis of OS in a single-agent UFT therapy. *Used random effect models.

Abbreviations: CI, confidence interval; IV, inverse variance; OS, overall survival; SE, standard error; UFT, tegafur–uracil.